Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Bristol-Myers Squibb Co. (NYSE:BMY) discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The 52-week range of Bristol-Myers Squibb stock price was $39.35 to $63.33. Bristol-Myers Squibb's dividend yield is 5.62%. It paid $2.48 per share in dividends during the last 12 months. Don't Miss: Hasbro, MGM, and Skechers trust this AI marketing firm — Invest at $0.60/share before it's too late. Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – Last Chance to get 4,000 of its pre-IPO shares for just $0.30/share! The Latest On Bristol-Myers Squibb On April 24, the company announced its Q1 2025 earnings, posting revenues of $11.20 billion, above the consensus estimate of $10.70 billion, as reported by Benzinga. The company reported adjusted EPS of $1.80, a turnaround from a loss of $4.40 a year ago, beating the consensus of $1.49. Bristol Myers Squibb raised its full-year 2025 adjusted EPS from the range of $6.55 to $6.85 to $6.70 to $7.00, compared to the consensus of $6.74. The U.S. drug giant also raised the 2025 sales guidance from $45.50 billion to the range of $45.80 billion to $46.80 billion, compared to the consensus estimate of $45.76 billion. Check out this article by Benzinga, which looks into Bristol-Myers Squibb’s price over earnings. Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — you can become an investor for $0.80 per share today. How Can You Earn $100 Per Month As A Bristol-Myers Squibb Investor? If you want to make $100 per month — $1,200 annually — from Bristol-Myers Squibb dividends, your investment value needs to be approximately $21,352, which is around 473 shares at $45.17 each. Understanding the dividend yield calculations: When making an estimate, you need two key variables — the desired annual income ($1,200) and the dividend yield (5.62% in this case). So, $1,200 / 0.0562 = $21,352 to generate an income of $100 per month. You can calculate the dividend yield by dividing the annual dividend payments by the current price of the stock. See Also: Nancy Pelosi Invested $5 Million In An AI Company Last Year — Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000. The dividend yield can change over time. This is the outcome of fluctuating stock prices and dividend payments on a rolling basis. For instance, assume a stock that pays $2 as an annual dividend is priced at $50. Its dividend yield would be $2/$50 = 4%. If the stock price rises to $60, the dividend yield drops to 3.33% ($2/$60). A drop in stock price to $40 will have an inverse effect and increase the dividend yield to 5% ($2/$40). Story Continues In summary, income-focused investors may find Bristol-Myers Squibb stock an attractive option for making a steady income of $100 per month by owning 473 shares of stock. Read Next: Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold. ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can invest today for just $0.30/share with a $1000 minimum. Image: Shutterstock Send To MSN: 0 This article Here's How You Can Earn $100 In Passive Income By Investing In Bristol-Myers Squibb Stock originally appeared on Benzinga.com View Comments
Here's How You Can Earn $100 In Passive Income By Investing In Bristol-Myers Squibb Stock
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...